Peter Attia· MD
niacin made the april-b go lower than statin and ezetimibe did by themselves so you got additional serious april-b lowering and will outcome reduction
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
niacin made the april-b go lower than statin and ezetimibe did by themselves so you got additional serious april-b lowering and will outcome reduction
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so the whole premise to let's spend money on the aim high trial because now we are in the statin or where you do have to give everybody a statin so we'll make everybody's LDL cholesterol perfect and by the way if a statin doesn't do it well that is that it might to it also so we will get ldl-c perfect but hdl-c is still going to be low so we're now gonna add nice